Below is a partial list of the companies that
will be presenting at this year's conference

June 1-2, 2016

* Important note about presenting companies

22nd Century Group, Inc.
22nd Century Group, Inc. (XXII)
Industry Sector: Retail and Consumer Products

22nd Century Group, Inc., is a plant biotechnology company that provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. The company is also developing a prescription smoking cessation aid, which is a tobacco-based botanical medical product; and modified risk cigarettes with approximately 95% less nicotine than conventional tobacco cigarettes, as well as cigarettes that contain low amounts of tar per milligram of nicotine. Through a recent collaboration with Anandia Laboratories, the company gained exclusive U.S. rights to genes required to produce cannabinoids, which are compounds that act on cannabinoid receptors of human cells, the most notable being THC. Technology licensed from Anandia allows for development of cannabis strains that increase or decrease the content of cannabinoids. The company was founded in 1998 and is headquartered in Clarence, New York.

Acme United Corporation
Acme United Corporation (ACU)
Industry Sector: Retail and Consumer Products

Acme United Corporation is a leading worldwide supplier of innovative cutting, measuring, first aid and sharpening products to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include Westcott®, Clauss®, Camillus®, Cuda®, PhysiciansCare®, First Aid Only®, Pac Kit® and DMT®. The Company has had six years of increasing sales and earnings, and has been recognized by Forbes, Business Week , and Fortune as among the fastest growing small companies in the U.S.

Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. (ATNM)
Industry Sector: Life Science and Healthcare

Actinium Pharmaceuticals, Inc., is a biopharmaceutical company that develops drugs for the treatment of cancer. The company develops therapies for life threatening diseases using its alpha particle immunotherapy platform and other related technologies. Its products include Actimab-A, an antibody-drug construct, which includes monoclonal antibody Lintuzumab and alpha emitting radioisotope actinium 225 and is in multicenter Phase I/II clinical trials for acute myeloid leukemia (AML). The company also offers Iomab-B, an antibody-drug construct that comprises the BC8 monoclonal antibody and beta emitting radioisotope iodine 131, and is used in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. Its Iomab-B is in preparation for a Phase III multicenter clinical trial for bone marrow conditioning for HSCT in relapsed and refractory AML patients. The company was founded in 2000 and is based in New York.

Akoustis Technologies Inc.
Akoustis Technologies Inc. (AKTS)
Industry Sector: Technology - Media and Internet

Akoustis™ is a high-tech RF filter solutions company that manufactures its unique, patent-pending Bulk ONE™ acoustic wave technology to produce single-crystal bulk acoustic wave (BAW) filters for the mobile-wireless industry, which facilitates signal acquisition and accelerates band performance between the antenna and the back end of mobile devices. The Bulk Acoustic Wave (BAW) filter market is rapidly expanding, driven by growth in 4G/LTE and the number of filters required per device. Akoustis' "fabless" business model is capital efficient, leveraging existing manufacturing infrastructure in the semiconductor industry. Akoustis™ is located in the Piedmont technology corridor between Charlotte and Raleigh, North Carolina. The company was founded in 2014 by experienced industry leaders and scientists from University of California at Santa Barbara (UCSB) and Cornell University.

Avalon Advanced Materials Inc.
Avalon Advanced Materials Inc. (AVLNF)
Industry Sector: Energy and Natural Resources

Avalon Advanced Materials Inc. (formerly Avalon Rare Metals Inc.) is a Canadian mineral development company with a primary focus on the rare metals and minerals, headquartered in Toronto, Canada. Avalon specializes in niche market metals and minerals with growing demand in new technology. The company has three advanced stage projects, all 100%-owned, providing investors with exposure to lithium, tin and indium, as well as rare earth elements, tantalum, niobium and zirconium. Avalon is currently focusing on its Separation Rapids Lithium Project near Kenora, Ontario, which has the potential to produce a high purity lithium concentrate for two separate markets: an industrial mineral product for the glass-ceramics sector and high purity lithium compounds for energy storage. Health and safety, social responsibility and leadership in environmental stewardship are corporate cornerstones.

Avant Diagnostics, Inc.
Avant Diagnostics, Inc. (AVDX)
Industry Sector: Life Science and Healthcare

Avant is a medical diagnostic technology company that specializes in biomarker tests that are based on querying large panels of proteins with exquisite precision. We are developing specialized tests that are cutting edge in medical testing and our OvaDx® Pre-Symptomatic Ovarian Cancer Screening Test is a leading breakthrough in commercializing these tests." Avant's first test, OvaDx®, is proposed for use in monitoring women diagnosed previously with ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to ovarian tumor cell development. Pre-clinical research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA 510(k) clearance, Avant intends to sell or license OvaDx®. Avant intends to utilize its public company stage to expand its portfolio of diagnostic tests in the future.

AYTU Bioscience, Inc.
AYTU Bioscience, Inc. (AYTU)
Industry Sector: Life Science and Healthcare

Aytu BioScience is a commercial-stage specialty healthcare company focused on global commercialization of novel products in the field of urology. Aytu's current portfolio of commercial and late-stage urology products addresses prostate cancer, urinary tract infections, male infertility and male sexual dysfunction, and the company plans to expand into other urological indications for which there are significant medical needs. The Company currently markets ProstaScint® (capromab pendetide), the only radio-labeled monoclonal antibody that targets prostate specific membrane antigen (PSMA), a protein highly expressed by prostate cancer cells. ProstaScint is FDA-approved as an imaging agent for use in both newly diagnosed, high-risk prostate cancer patients and patients with recurrent prostate cancer. Aytu also markets Primsol® (trimethoprim hydrochloride) – the only FDA-approved trimethoprim-only oral solution for urinary tract infections. Additionally, Aytu markets the CE Marked MiOXSYS™ System outside the U.S. and is conducting U.S.-based clinical trials, following which the Company expects to receive 510k de novo medical device clearance. The MiOXSYS System is a novel, rapid semen analysis system with the potential to become a standard of care in the diagnosis and management of male infertility. MiOXSYS is the only rapid test for assessing oxidative stress in semen and seminal plasma, a leading contributor of idiopathic male infertility. Aytu's strategy is to continue building its portfolio of revenue-generating urology products and late-stage development assets, leveraging its commercial team and expertise to further build those brands within well-established markets.

Be Active Brands, Inc.
Be Active Brands, Inc. (JALA)
Industry Sector: Retail and Consumer Products

Be Active Brands, Inc. is a manufacturer and marketer of Greek frozen yogurt under the Jala brand. The Company manufactures and sells low fat, low calorie, all natural probiotic enriched Greek frozen yogurt under the trade name Jala. Its Greek frozen yogurt is packaged as low fat bars and pints, which are designed to appeal both the health conscious and weight conscious consumer. The Company produces high quality, low fat, low calorie, all natural novelty frozen yogurt and ice cream products. Its proprietary Greek frozen yogurt is all fat-free and is a result of its proprietary recipe and the quality of the ingredients in the mix.

BG Staffing
BG Staffing (BGSF)
Industry Sector: Software and Business Services

Headquartered in Plano, Texas, BG Staffing is a national provider of temporary staffing services across a diverse set of industries. The Company has grown revenue from approx. $40 million in 2010 to $217 million in 2015 (approx. 25% increase over 2014), through both organic growth and accretive acquisitions. The Company pays a $0.25 quarterly dividend. L. Allen Baker, Jr., President and CEO, has been in the staffing industry since 1985, having made more than 20 successful acquisitions in his career. At BGSF, Baker has closed and successfully integrated seven accretive acquisitions.

Bio-Key International, Inc.
Bio-Key International, Inc. (BKYI)
Industry Sector: Software and Business Services

BIO-key is revolutionizing security and user authentication, as our easy-to-use biometric solutions enable convenient and secure information access and transactions, whether in-person or online. Our state-of-the-art software solutions eliminate the need for passwords, PINs, tokens and cards, and make it easy for enterprises and consumers to secure their devices as well as their information in the cloud. In addition, BIO-key’s finger scanning devices SideTouch, SideSwipe and EcoID offer market leading quality, performance and price.

BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (BRTX)
Industry Sector: Life Science and Healthcare

BioRestorative Therapies develops therapeutic products primarily involving adult stem cells.

Disc/Spine: BRTX-100 is a product formulated from autologous mesenchymal stem cells collected from bone marrow. We intend that the product will be used for the non-surgical treatment of lumbar discs in patients suffering from chronic lumbar disc disease. BRTX-100 is injected into the patient's damaged disc in an outpatient procedure. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery.

Metabolic: Allogeneic therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. Initial research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.

BioSculpture Technology, Inc.
BioSculpture Technology, Inc. (Private)
Industry Sector: Life Science and Healthcare

BioSculpture Technology, Inc. ("BST") is a commercial stage medical device manufacturer developing a patented and prototyped minimally invasive procedure and device for the direct endoscopic removal of visceral or "belly" fat as a new treatment of obesity, metabolic syndrome and type 2 diabetes mellitus.  We believe our method and device will save lives, improve life outcomes, and significantly reduce healthcare costs.

2/3 of the U.S. population is overweight and 43% is forecast to be obese in a few years.  Obesity related disease expenditures exceeded $2 Trillion and obesity medical device expenditures exceeded $2.0 Billion in 2015.  Current bariatric procedures are highly invasive, involve significant risks and life-changing compromises.  There is an enormous unmet need for a minimally invasive treatment of obesity that is safer and highly effective. 

BST plans a tier 2 Reg. A Offering to bring this treatment to the billions of obese patients who can benefit from it.

BioSig Technologies, Inc.
BioSig Technologies, Inc. (BSGM)
Industry Sector: Life Science and Healthcare

BioSig Technologies, Inc. is an emerging-growth medical device company that is developing a proprietary technology platform aimed at the rapidly growing $3 billion electrophysiology marketplace. A proven management team, world-class Board of Directors and renowned Scientific Advisory Board, leads the Minneapolis based company. Currently, the Company is preparing to commercialize their PURE EP™ System. PURE EP is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time. PURE EP acquires and displays high-fidelity cardiac signal recordings at previously undetectable levels with astounding accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that otherwise create a heart rhythm disturbance (arrhythmia). PURE EP is an innovative platform, that offers life-saving benefits compared to competitors' technologies; including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of repeat procedures.

Bridgeline Digital Inc.
Bridgeline Digital Inc. (BLIN)
Industry Sector: Software and Business Services

Bridgeline Digital, The Digital Engagement Company™, helps customers maximize the performance of their full digital experience – from websites and intranets to online stores and campaigns. Bridgeline’s iAPPS platform deeply integrates Web Content Management, eCommerce, eMarketing, Social Media management, and Web Analytics to help marketers deliver digital experiences that attract, engage and convert their customers across all channels. Headquartered in Burlington, Mass., Bridgeline has thousands of quality customers that range from small- and medium-sized organizations to Fortune 1000 companies.

Capnia, Inc.
Capnia, Inc. (CAPN)
Industry Sector: Life Science and Healthcare

Capnia, Inc. develops and commercializes novel products based on its proprietary technologies for precision metering of gas flow. Capnia's lead product CoSense® is based on the Sensalyze™ Technology Platform. It is a portable, non-invasive device that rapidly and accurately measures carbon monoxide (CO) in exhaled breath. CoSense has 510(k) clearance for sale in the U.S. and has received CE Mark certification for sale in the European Union. CoSense is used for the monitoring of CO from internal sources (such as hemolysis, a dangerous condition in which red blood cells degrade rapidly), as well as external sources (such as CO poisoning and smoke inhalation). The initial target market is newborns with jaundice that are at risk for hemolysis, comprising approximately three million births in the U.S. and European Union. Capnia's proprietary therapeutic technology uses nasal, non-inhaled CO2 and is being evaluated to treat the symptoms of allergies, as well as the trigeminally mediated pain conditions such as cluster headache, trigeminal neuralgia and migraine.

Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. (CLRB)
Industry Sector: Life Science and Healthcare

Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. Cellectar's PDC Delivery Platform is based on the company's proprietary phospholipid ether analogs. These novel small-molecules have demonstrated highly selective uptake and retention in a broad range of cancers. Cellectar's PDC pipeline includes product candidates for cancer therapy and cancer diagnostic imaging. The Company's lead therapeutic PDC, CLR 131, utilizes iodine-131, a cytotoxic radioisotope, as its payload. CLR 131 is currently being evaluated under an orphan drug designated Phase 1 study in patients with relapsed or refractory multiple myeloma. The company is also developing PDCs for targeted delivery of chemotherapeutics such as paclitaxel (CLR 1602-PTX), a pre-clinical stage product candidate, and plans to expand its PDC chemotherapeutic pipeline through both in-house and collaborative R&D efforts.

Cel-Sci Corp
Cel-Sci Corp (CVM)
Industry Sector: Life Science and Healthcare

CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. Its lead investigational therapy is Multikine (Leukocyte Interleukin, Injection), currently being studied in a pivotal global Phase III clinical trial. Multikine is the first immunotherapeutic agent being developed as a potential first-line treatment for advanced primary head and neck cancer. CEL-SCI is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its LEAPS technology platform. The investigational immunotherapy LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu, as CEL-SCI scientists are very concerned about the possible emergence of a new more virulent hybrid virus through the combination of H1N1 and Avian Flu, or maybe Spanish Flu. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.

Ceres, Inc.
Ceres, Inc. (CERE)
Industry Sector: Life Science and Healthcare

Ceres is an agricultural biotechnology company focused on forage and feed crops. The company uses a combination of advanced plant breeding, biotechnology and bioinformatics to develop forages with a better balance of yield, energy and nutrition. The company markets its improved seed products under its Blade brand. Ceres also licenses its biotech traits and technology, including its Persephone genome visualization software, to other life science companies and organizations. Ceres is based in Thousand Oaks, California.

Cesca Therapeutics
Cesca Therapeutics (KOOL)
Industry Sector: Life Science and Healthcare

Cesca Therapeutics is engaged in research, development and commercialization of cellular therapeutics and devices for use in regenerative medicine and hematological and oncological applications. We serve patients, physicians and partners through technologies that address cellular therapeutics, medical/diagnostic devices, cell manufacturing and cryopreservation. Along with our proprietary automated devices for concentration of therapeutic stem cells from blood, we are currently undertaking an FDA-approved pivotal trial to treat late stage critical limb ischemia (CLI) with our SurgWerks™ Platform for the delivery of regenerative cell therapy for vascular disease and orthopedic indications.

The Company is based out of Rancho Cordova, California, with offices in Emeryville, California and Delhi, India.

ChromaDex Corporation
ChromaDex Corporation (CDXC)
Industry Sector: Life Science and Healthcare

ChromaDex Corp. is a natural products company that leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to the Company's proprietary ingredient technologies segment, the Company also has a core standards and contract services segment, which focuses on natural product fine chemicals (known as "phytochemicals") and chemistry and analytical testing services and a regulatory consulting segment (known as Spherix Consulting). As a result of the Company's relationships with leading universities and research institutions, the Company is able to discover and license early stage, intellectual property-backed ingredient technologies. The Company then utilizes the Company's business segments to develop commercially viable proprietary ingredients. The Company's proprietary ingredient portfolio is backed with clinical and scientific research, as well as extensive intellectual property protection.

Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. (CTXR)
Industry Sector: Life Science and Healthcare

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and commercializes therapeutic products. They offer Suprenza ODT, a phentermine orally disintegrating tablet, used for the treatment of obesity. Its products also include Hydrocortisone-Lidocaine Cream, which is under phase II of clinical trial for the treatment of hemorrhoids. The company has a collaboration and license agreement with Alpex Pharma S.A. to develop and commercialize orally disintegrating tablet formulations of pharmaceutical products throughout North America. Recently, they announced that they were acquiring Leonard Meron, late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration on anti-infective drugs. Founder and CEO, Leonard Mazur previously served as Executive VP at Medicis Pharmaceutical Corporation and VP of Sales & Marketing at ICN Pharmaceuticals, Inc. (Now Valeant)/, Knoll Pharma, (Unit of BASF). Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Maynard, Massachusetts.

Coffee Holding Company, Inc.
Coffee Holding Company, Inc. (JVA)
Industry Sector: Retail and Consumer Products

Coffee Holding Company is a horizontally and vertically integrated coffee roaster with a 45 year history of success in the highly fragmented and highly competitive coffee industry. Our horizontally integrated business model, selling both roasted and raw green specialty Arabica coffees to both large retailers and smaller regional roasters, has allowed us to maintain profitability in the varying commodity and economic cycles over the past four and one half decades. We have an international presence in the industry with sales throughout North America, the Caribbean, Europe and the Pacific Rim. Our vertical integration, where we source at Farmgate, has given us direct access to a stable supply of high quality coffee beans which we roast and resell to our customers ensuring their continued satisfaction and loyalty to our company, enabling us to grow both our top line revenues, customer base and overall reputation within the industry.

CohBar, Inc.
CohBar, Inc. (CWBR)
Industry Sector: Life Science and Healthcare

CohBar, Inc. is a leader in the research and development of mitochondria-based therapeutics (MBTs), an emerging class of drugs for the treatment of diseases associated with aging. MBTs originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. This groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. MBTs offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders. We are currently selecting a clinical candidate for our lead program, MOTS-c, prior to initiating IND enabling studies.

CombiMatrix Corporation
CombiMatrix Corporation (CBMX)
Industry Sector: Life Science and Healthcare

CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in prenatal diagnostics, miscarriage analysis /recurrent pregnancy loss, pediatric genetics and pre-implantation genetic screening, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. CombiMatrix is dedicated to providing high-level clinical support for healthcare professionals in order to help them incorporate the results of complex genetic testing into patient-centered medical decision making.

ContraVir Pharmaceuticals
ContraVir Pharmaceuticals (CTRV)
Industry Sector: Life Science and Healthcare

ContraVir is a biopharmaceutical company focused on the discovery and development of targeted antiviral therapies with two candidates in mid-to-late stage clinical development. ContraVir’s lead clinical drug, FV-100, is an orally available nucleoside analogue prodrug that is being developed for the treatment of herpes zoster, or shingles, which is currently in Phase 3 clinical development. In addition to direct antiviral activity, FV-100 has demonstrated the potential to reduce the incidence of debilitating shingles-associated pain known as post-herpetic neuralgia (PHN) in a Phase 2 clinical study. ContraVir is also developing CMX157, a highly potent analog of the successful antiviral drug tenofovir, for the Hepatitis B virus. CMX157’s novel structure results in decreased circulating levels of tenofovir, lowering systemic exposure and thereby reducing the potential for renal and bone side effects.

COPsync, Inc.
COPsync, Inc. (COYN)
Industry Sector: Technology - Media and Internet

COPsync is America’s largest law enforcement real-time information sharing, communication and data interoperability Network. With COPsync, officers instantly access local, state, and federal law enforcement databases, efficiently gather information at the point of incident, and immediately share critical data with all officers on the COPsync Network.

Dataram Corporation
Dataram Corporation (DRAM)
Industry Sector: Technology - Media and Internet

Dataram Corporation is a leading independent manufacturer of memory products and provider of performance solutions that increase the performance and extend the useful life of servers, workstation, desktops and laptops. The Company's memory products and solutions are sold worldwide to OEMs, distributors, value-added resellers, end users and leading manufacturers such as Dell, Cisco, Fujitsu, HP, IBM, Lenovo and Oracle. Founded in 1967, the Company has established a rich history and strong presence in the United States, Europe and Asia. Over the past 14 months, Dataram with investor support has appointed new leadership (CEO, CFO, and Board of Directors) to refocus and bring the Company back to sustainability and profitability which it is projected to achieve in the first two quarters of full year 2016. The turnaround strategy has already delivered more than $4 million in net cash savings to date.

Direct Insite Corp
Direct Insite Corp (DIRI)
Industry Sector: Software and Business Services

Direct Insite™ provides a powerful platform for unified working capital management that facilitates over $160 billion worth of transactions annually between more than 375,000 companies worldwide.  Direct Insite’s clients include IBM, Siemens, BE Aerospace, Saint Gobain, Carlson, and one of the largest financial institutions in the world.  The flagship component of Direct Insite’s unified working capital management platform is PAYBOX™, an innovative receivables automation solution that combines electronic invoicing, online approvals and adjustments, electronic payments, and integration with any legacy accounting, ERP or lockbox system.  PAYBOX™ is primarily sold through banks to corporate users of their treasury management and lockbox services.  Banks and corporations use PAYBOX™ to reduce Days Sales Outstanding, lower costs, and improve straight-through AR posting.

Dyadic International, Inc.
Dyadic International, Inc. (DYAI)
Industry Sector: Life Science and Healthcare

Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant protein production system based on the fungus Myceliopthora thermophila, nicknamed C1. The C1 microorganism, which enables the development and large scale manufacture of low cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development and production of biologic drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines, monoclonal antibodies, biosimilars and/or biobetters, and other therapeutic proteins. Dyadic pursues research & development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in developing and manufacturing biopharmaceuticals which these technologies help produce. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic drugs to market faster, in greater volumes and at lower cost to drug developers and manufacturers and, hopefully, improve access and cost to patients and the healthcare system.

EyeGate Pharmaceuticals Inc.
EyeGate Pharmaceuticals Inc. (EYEG)
Industry Sector: Life Science and Healthcare

EyeGate Pharma is a late-stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery mechanisms for treating diseases of the eye. EyeGate’s technology addresses two of the most prevalent issues in ophthalmic care; the existing lack of patient adherence and patient safety. EyeGate Pharma is committed to advancing their delivery technology and therapeutic candidates with a goal of bringing new, potentially superior treatment options to patients who will most likely benefit.  

Finjan Holdings, Inc.
Finjan Holdings, Inc. (FNJN)
Industry Sector: Technology - Media and Internet

Finjan, founded in 1997, is a technology company committed to investing in and enabling technology innovation. Our early technology innovations and products helped define the state-of-the-art for detecting and deflecting software intrusions and malicious code delivery, over internet and private networks, to devices located at endpoint connections. Beginning with the formation of the company, we have invested considerable time, effort and resources to secure our inventions with US and Foreign patents. As Finjan’s patented technologies have become increasingly relevant across today’s growing security sector, we continue to seek licenses to our patents across the industry. Finjan has successfully licensed its patents to a number of industry players, demonstrated a strong commitment to pursuing unlicensed companies through litigation, resulting in more than $145 million in licensing revenues, to date. The company continues to invest in the security sector and intends to broaden its technology and intellectual property holdings through continued acquisition, investment, and strategic partnerships.

FTE Networks, Inc.
FTE Networks, Inc. (FTNW)
Industry Sector: Technology - Media and Internet

FTE Networks, Inc. designs, builds, and supports wireless and wireline networking infrastructures for the IT and telecommunications industries. We enable our customers to connect to their customers by providing a high performance networking infrastructure to ensure fast, reliable and secure voice, data and digital content delivery.

With our integrated end to end networking engineering approach, wealth of industry experience and strong customer relationships, FTE helps companies expand their market presence, improve performance and agility, and control costs.

Founded in 2007, FTE Networks, Inc. is headquartered in Naples, Florida, with offices throughout the United States and Europe.

Fuling Global Inc.
Fuling Global Inc. (FORK)
Industry Sector: Industrials

Fuling Global Inc. ("Fuling Global") is a specialized producer and distributor of environmentally friendly plastic serviceware, with precision manufacturing facilities in both the U.S. and China. The Company's plastic serviceware products include disposable cutlery, drinking straws, cups, plates and other plastic products and are used by more than one hundred customers primarily from the U.S. and Europe, including Subway, Wendy's, Burger King, KFC (China only), Walmart, McKesson, and Woolworths.

General Employment Enterprises, Inc.
General Employment Enterprises, Inc. (JOB)
Industry Sector: Software and Business Services

General Employment Enterprises, Inc. was incorporated in the State of Illinois in 1962, is a provider of specialized staffing solutions and is the successor to employment offices doing business since 1893. The Company operates in two industry segments, providing professional staffing services and solutions in the information technology, engineering, finance and accounting specialties and light industrial staffing services through the names of General Employment, Access Data Consulting, Agile Resources, Ashley Ellis, Omni-One, Paladin Consulting and Triad. Also, in the healthcare sector, General Employment, through its Scribe Solutions brand, staffs medical scribes who assist physicians in emergency departments of hospitals and in medical practices by providing required documentation for patient care in connection with electronic medical records (EMR).

Green PolkaDot Box Incorporated
Green PolkaDot Box Incorporated (GPDB)
Industry Sector: Retail and Consumer Products

Green PolkaDot Box Incorporated ("GPDB" or the "Company"), a publicly traded company, is an online food distributor that is solving enormous food problems in the United States: (1) the high cost and limited availability of CLEAN foods; and (2) the proliferation of GMO contaminated foods that have pervaded more than 70% of the food supply.

GPDB specializes in the provisioning and sales of thousands of popular brand organic and non-GMO or "CLEAN" foods to its growing collective Health Merchants™ and their customers. Health Merchants use GPDB proprietary marketing technology and creative content to market and sell GPDB's CLEAN food offering directly to their own customers, while GPDB provides the infrastructure and logistics for their orders and fulfillment.

GPDB has already enrolled 276 Health Merchants that reach over 45-million customers and its numbers are growing rapidly.

Grom Social, Inc.
Sponsoring Presenting Company
Grom Social, Inc. (Private)
Industry Sector: Technology - Media and Internet

Grom Social, Inc., ("Grom"), an exciting pre-IPO opportunity, is a highly interactive social media platform/website, "By Kids for Kids", founded by 12 year old Zach Marks. In three years, Grom has grown to nearly 3 million users in over 200 countries and territories and has been publicized in 375 media outlets.

In recent months under the direction of Sander Schwartz, the Company's president and former president at Warner Brothers Animation, the Company has assembled an advisory board made up of industry titans. In addition, it has completed an acquisition of an interactive social media company and signed a binding LOI to acquire a profitable animation company, subject to obtaining financing, which will be immediately accretive.

The Company is now positioned to become the "Media Destination for Kids in the 21st Century", think "Kids Facebook Meets Instagram with a Touch of Disney Animation Magic"., Inc., Inc. (HEWA)
Industry Sector: Technology - Media and Internet, Inc. is America’s Trusted Online Pharmacy, licensed in 50 states to focus on the out-of-pocket prescription drug market, a market which is expected to grow to over $80 billion in 2016. is currently 1 of less than 45 Verified Internet Pharmacy Practice Websites (“VIPPS”) accredited by the National Association of Boards of Pharmacy (“NABP”) and is the only VIPPS accredited pharmacy licensed in all 50 states that processes out-of-pocket prescriptions online. The Company is a four time winner of the BizRate Circle of Excellence Award for outstanding customer service and satisfaction and was recognized by major consumer publications as having the lowest price among top US pharmacies for commonly prescribed medications.

IEG Holdings Corporation
IEG Holdings Corporation (IEGH)
Industry Sector: Technology - Media and Internet

IEG Holdings Corporation is an online unsecured consumer loan lender operating under the brand name, "Mr. Amazing Loans." Via its website, lends $5,000 loans over a term of five years at a 23.9% to 29.9% APR in 17 US states, with plans to expand to 25 US states during 2016. Qualifying customers receive $5,000 the same day of application with zero application fees, establishment fees or prepayment penalties and in return make affordable weekly principal and interest repayments totaling $37.03 a week.

ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics, Ltd. (IMUC)
Industry Sector: Life Science and Healthcare

ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

Inventergy Global, Inc.
Inventergy Global, Inc. (INVT)
Industry Sector: Technology - Media and Internet

Inventergy Global, Inc. is an intellectual property company dedicated to identifying, acquiring and licensing the patented technologies of market-significant technology leaders. Led by former head of IP licensing at Hewlett-Packard, Joe Beyers, the company draws upon decades of corporate experience and market and technology expertise, as well as industry connections, to assist its clients including Fortune 500 companies, in leveraging the value of their innovations to achieve greater returns. Inventergy leverages an experienced team that has brokered more than $15 billion in IP and technology transactions. The company offers a professional corporate licensing model for IP value creation that provides short-term returns and long-term licensing revenue. The company acquires portfolios in the telecommunications industry primarily in IP multimedia subsystems and voice over IP; and mobile broadband communications segments. Inventergy Global, Inc. is headquartered in Campbell, California.

Iveda Solutions
Iveda Solutions (IVDA)
Industry Sector: Technology - Media and Internet

Iveda Solutions enables cloud video surveillance via its Sentir™ Software as a Service (SaaS) video management platform, utilizing proprietary video streaming and Big Data storage technology. Iveda enables a recurring revenue model by licensing Sentir to service providers (e.g., telecoms, ISPs, data centers, cable companies) for plug-and-play cloud video offering to their customers. Iveda Solutions has a SAFETY Act Designation by the Department of Homeland Security as a Qualified Anti-Terrorism Technology provider.

Industry Sector: Technology - Media and Internet

IZEA operates the premier online marketplace that connects brands with influential content creators. IZEA creators range from leading bloggers and social media personalities to A-List celebrities and professional journalists. Creators are compensated for developing and distributing unique content on behalf of brands including long form text, videos, photos and status updates. Brands receive influential consumer content and engaging, shareable stories that drive awareness.

Legacy Education Alliance, Inc.
Legacy Education Alliance, Inc. (LEAI)
Industry Sector: Retail and Consumer Products

Legacy Education Alliance, Inc. is a leading international provider of practical, high-quality, and value-based educational training on the topics of personal finance, entrepreneurship, real estate and financial markets investing strategies and techniques. Legacy Education Alliance was founded in 1996, and through a reverse merger, became a publicly-held company in November 2014. Today we are a global company with approximately 200 employees that has cumulatively served more than two million students from more than 150 countries and territories over the course of our operating history. We manage our business in four segments based on geographic location. These segments include our historical core markets of the United States, Canada, and the United Kingdom, with the fourth segment including all other international markets.

We offer our training through a variety of brands including Rich Dad® Education; Rich Dad Stock Education; Making Money From Property With Martin Roberts; Brick Buy Brick; Building Wealth™; Robbie Fowler Property Academy; Women in Wealth; The Independent Woman; Trade Up Investor Education; and Elite Business Star.

Long Island Iced Tea Corp.
Sponsoring Presenting Company
Long Island Iced Tea Corp. (LTEA)
Industry Sector: Retail and Consumer Products

Long Island Iced Tea Corp. operates in the ready-to-drink tea segment of the beverage industry. The Company has developed non-alcoholic, premium iced tea bottled beverages made with quality ingredients that are offered at an affordable price. The Company is currently organized around its flagship brand Long Island Iced Tea, a premium, ready-to-drink, proprietary recipe iced tea sold primarily on the East Coast of the United States through a network of national and regional retail chains and distributors.

Mace Security International, Inc.
Mace Security International, Inc. (MACE)
Industry Sector: Retail and Consumer Products

Mace Security international, Inc, located in Cleveland, Ohio, is a diversified manufacturer and provider of personal defense and security products to consumer and business market segments under the world renowned Mace® Brand. Since 1970, Mace® Brand has been the original trusted brand for personal defense sprays, while continuously adding high quality security products to the brand line through the years. Mace® Brand supports their products by providing warranty and educational programs for all of various products and services.

Mace® Brand directly distributes and supports it's branded products and services through strategically targeted customer channels that include mass market retailers, wholesale distributors, independent dealers, e-commerce marketers, and installation service providers.

MagnaGas (MNGA)
Industry Sector: Energy and Natural Resources

MagneGas® Corporation. The Company owns a patented process that converts various liquid wastes into hydrogen based fuels. These fuels can be used as a replacement to natural gas or for metal cutting. The Company's testing has shown the fuels are faster, cleaner and more productive than other alternatives on the market. They are also cost effective and safe to use with little changeover costs.  The Company currently sells MagneGas® into the metal working market as a replacement to acetylene.

The MagneGas fuel production systems can be set-up locally using various types of feedstock. The Company believes this flexibility can give them an advantage in the Government/Military marketplace as fuels can be manufactured on site from raw materials found locally worldwide and eliminates the time and expense of shipping to the specific location. The Company is planning to establish joint ventures with third parties to construct these supply facilities worldwide.

The Company also sells equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets. In addition, the Company is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature for co-combustion of hydrocarbon fuels and other advanced applications.

Medical Transcription Billing Corp.
Medical Transcription Billing Corp. (MTBC)
Industry Sector: Life Science and Healthcare

MTBC went public in July 2014, purchasing the assets of three medical billing companies for a combination of cash and stock on the date the IPO closed. These have now been successfully integrated with its existing business. In the same way that athenahealth (Nasdaq: ATHN) currently dominates the healthcare information technology market for large doctor practices, MTBC is targeting the fragmented 1-10 doctor market, with a highly-rated proprietary SaaS platform that integrates revenue cycle management with electronic health records, practice management and mobile health.

New government regulations like ICD-10 are putting pressure on industry participants who lack our technology and access a low cost offshore workforce. 95% of our current global workforce of 2,000 is located in Pakistan, where labor costs are approximately 1/2 the cost of comparable India-based employees and 1/10th the cost of comparable U.S. employees. Our growth strategy includes acquiring such revenue cycle management companies and migrating their customers to our platform, as well as forging strategic partnerships with other industry participants, including electronic health records vendors.

NanoViricides, Inc.
NanoViricides, Inc. (NNVC)
Industry Sector: Life Science and Healthcare

NanoViricides, Incorporated is a pre-clinical biotech company that has utilized its patented platform technology to rapidly create anti-viral drug candidates in the space of months. These drugs actually destroy, as opposed to merely slowdown, the invading virus in the circulation, on the skin or on the surface of the eye. The Company has tested its drug candidates in over 6,000 animals without evidence of resistance, side effects or toxicity. These tests have been conducted on animals infected with various strains of influenza, HIV, dengue/dengue hemorrhagic fever, Ebola, rabies, adenovirus of the eye as well as herpes infections of the skin and the eye. The Company's 25 scientists work in a large, ultra modern, research, development and manufacturing facility in Shelton, CT. Treatments for various forms of acute herpes infections are now being advanced through the pre-clinical process towards human trials.

Neurotrope Bioscience, Inc.
Neurotrope Bioscience, Inc. (NTRP)
Industry Sector: Life Science and Healthcare

Neurotrope, Inc. is at the forefront of biotechnology companies having a focus on developing a novel therapy for the treatment of moderately severe to severe Alzheimer's disease. The scientific basis of our treatment is activation of Protein Kinase C isozymes ε and α by bryostatin, a natural product, which can result in repair of damaged synapses as well as synaptogenesis, reduction of toxic amyloid generation, and enhancement of memory and learning, thus having the potential to improve cognition and behavior in Alzheimer's disease. Neurotrope is also conducting preclinical studies of bryostatin for Fragile X Syndrome and Niemann-Pick Type C disease, two rare genetic diseases for which only symptomatic treatments are currently available. The FDA has granted us Orphan Drug Designation for bryostatin as a treatment for Fragile X Syndrome. Bryostatin has undergone testing in over 1,400 people establishing a large safety database. NTRP has exclusively licensed technology from the Blanchette Rockefeller Neurosciences Institute for Alzheimer's disease and Fragile X Syndrome, has a world-wide, exclusive license with the Icahn School of Medicine at Mt. Sinai for Niemann-Pick Type C disease and is partnered with Stanford University to synthesize and find the next generation bryostatin.

Nuvo Pharmaceuticals Inc.
Nuvo Pharmaceuticals Inc. (NRI)
Industry Sector: Life Science and Healthcare

Nuvo is a growing, profitable commercial healthcare business with a portfolio of commercial products and pharmaceutical manufacturing capabilities. Nuvo Pharma has three FDA approved commercial products that are sold in a number of countries, Pennsaid 2%, Pennsaid and the HLT Patch. Nuvo Pharma’s lead product, Pennsaid 2%, is marketed in the United States by Horizon Pharma. Nuvo Pharma is focused on making Pennsaid 2% a global brand by out-licensing its marketing rights, as well as strategic acquisitions and new contract manufacturing opportunities to increase its commercial product portfolio and to expand its royalty income and manufacturing revenues.

Oasmia Pharmaceutical AB
Oasmia Pharmaceutical AB (OASM)
Industry Sector: Life Science and Healthcare

Oasmia Pharmaceutical is a late-stage Swedish biopharma company that has traded in Sweden for approximately 10 years and also listed on Nasdaq. Oasmia researches, develops, and manufactures drugs for human and veterinary oncology. It focuses on manufacturing formulations based on cytostatics. Their approved products are used for the treatment of mammary carcinoma and squamous cell carcinoma in dogs; and for the treatment of ovarian cancer. Their next generation chemotherapy delivery system can deliver chemotherapy using a highly water-soluble agent, which show improved properties compared to other approved treatments. Oasmia's lead health program recently completed clinical Phase III and has been approved and is now being sold, with combination of carboplatin, for treatment of ovarian cancer in Russia and the CIS (former Russian Republics). Oasmia recently submitted a marketing plan to the EU for approval and expects to submit final data to the FDA sometime in 2016.

Ocean Power Technologies
Ocean Power Technologies (OPTT)
Industry Sector: Energy and Natural Resources

Headquartered in Pennington, New Jersey, Ocean Power Technologies is a pioneer in ocean wave energy conversion. OPT's proprietary PowerBuoy® technology is based on a scalable and modular design which allows for flexibility in meeting customer power requirements. OPT specializes in cost-effective and environmentally sound ocean wave based power generation and energy storage technology.

PCM, Inc.
PCM, Inc. (PCMI)
Industry Sector: Technology - Media and Internet

PCM, Inc. is a leading multi-vendor provider of technology products, services and solutions offered through our dedicated sales force, field and internal service teams, direct marketing channels and state of the art owned and operated data centers. Since our founding in 1987, we have served our customers by offering products and services from vendors such as Adobe, Apple, Cisco, Dell, Hewlett Packard Enterprise, HP Inc., Lenovo, Microsoft, Samsung, Symantec and VMware. We add additional value by incorporating products and services into comprehensive solutions. Our sales and marketing efforts allow our vendor partners to reach multiple customer segments including small, medium and enterprise businesses, state, local and federal governments and educational institutions.

PEN Inc.
Industry Sector: Life Science and Healthcare

At PEN, we're harnessing nanotechnology, the science of the infinitely small, in products that have big impact on health, safety and sustainability. They perform better, faster, smarter, stronger, cleaner – to make every day better for people and the planet. From healthcare to homecare, homeland defense to food security, transportation to recreation, products from our family of companies are transforming the way we live, work and play.

Petroshare Corp
Petroshare Corp (PRHR)
Industry Sector: Energy and Natural Resources

Petroshare Corp is a Denver, CO based energy company targeting economic, unconventional resource plays that generate solid returns on capital deployed at current commodity pricing of $35 per barrel of oil. The Company is focused on asset acquisition and development in quality core areas in the Niobrara / Codell fairway of the DJ Basin in NE Colorado. Petroshare's industry veterans have successfully navigated previous commodity down cycles and have the expertise to capitalize on acquisition opportunities. With low G&A, capital is applied to drilling, completion and production infrastructure rather than support of an over levered balance sheet. Petroshare safely and efficiently develops projects with low impact and minimal surface footprint. Multi-well pad facilities, designed and constructed with all stakeholders in mind, utilize subsurface pipelines to deliver product to market with less traffic and fewer surface storage facilities.

PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc. (PMBC)
Industry Sector: Life Science and Healthcare

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box®".

PharmaCyte's treatment for cancer involves encapsulating genetically modified live cells capable of converting an inactive chemotherapy drug (ifosfamide) into its "cancer-killing" form. These encapsulated live cells are placed as close to a cancerous tumor as possible. Once implanted in a patient, ifosfamide is given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been placed. When ifosfamide, which is normally activated in the liver, comes in contact with the encapsulated live cells, activation of the drug takes place at the source of the cancer without any side effects from the chemotherapy. This "targeted chemotherapy" has proven remarkably same and effective to use in past clinical trials.

PharmaCyte is also developing a treatment for Type 1 diabetes and Type 2 insulin-dependent diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and secrete insulin at levels in proportion to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box® technology.

PositiveID Corporation
PositiveID Corporation (PSID)
Industry Sector: Life Science and Healthcare

PositiveID Corporation is a life sciences tools and diagnostics company, with an extensive patent portfolio, that specializes in biological detection and molecular diagnostic systems for homeland defense and the global healthcare market. PositiveID develops microfluidic systems in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need. The Company's Firefly Dx is a handheld pathogen detection system that uses real-time PCR chemistry to identify biological threats at the point of need in less than 30 minutes. PositiveID is also a leader in the mobile technology vehicle market, through its E-N-G Mobile Systems subsidiary, with a focus on the laboratory market, communications, and homeland security. The Company's Thermomedics subsidiary markets the FDA-cleared Caregiver® non-contact thermometer, which features TouchFree technology and is targeting the fastest growing segment of the temperature monitoring device market.

Powerstorm ESS
Powerstorm ESS (PSTO)
Industry Sector: Energy and Natural Resources

At PowerstormESS, we sell more than batteries. We build advanced modular energy storage systems that provide economic & energy resilience for businesses, cities, and society – saving money, generating revenue, increasing resilience, and optimizing energy usage. We have decades of experience in battery system design and manufacturing, and use that expertise to provide you with turn-key solutions.

Our zeroXess platform is offering energy-efficient, high quality off-grid appliances to this expanding market where it will be well positioned for brand loyalty and sales growth. Tackling energy poverty will have less to do with ambitious expansion of electricity capacity, and more to do with ambitious distribution of energy services to poor people" We have to embrace failure and almost get a kick out of it. Not in a perverse way, but in a problem-solving way.

Pressure BioSciences, Inc.
Pressure BioSciences, Inc. PBIO
Industry Sector: Life Science and Healthcare

Pressure BioSciences, Inc. develops, markets, and sells proprietary laboratory instrumentation and consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and high levels to safely and reproducibly control bio-molecular interactions. Over 250 PCT systems have been installed in about 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders.

Primary PCT applications are in the biomarker discovery, drug discovery & design, and forensics areas. Our products are also used in bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.

In January 2016, we announced an exclusive, two-year co-marketing agreement with SCIEX, a global leader in life sciences analytical technologies.

Progressive Care, Inc.
Progressive Care, Inc. (RXMD)
Industry Sector: Life Science and Healthcare

Progressive Care, Inc. through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities. Progressive Care is a growth stage company with approximately $14 million in annual revenues and market cap of $11 million. The Company is expanding rapidly by increasing it marketing presence, developing new custom compounds, pursuing pharmacy licenses in all 50 states and evaluating several merger and acquisition targets. The Company expects to build cash and deliver earnings by the end of 2016.

Provectus Biopharmaceuticals, Inc.
Provectus Biopharmaceuticals, Inc. (PVCT)
Industry Sector: Life Science and Healthcare

Provectus Biopharmaceuticals, Inc., specializes in developing oncology and dermatology therapies. PV-10, its novel investigational drug for cancer, is designed for injection into solid tumors (intralesional administration), thereby reducing potential for systemic side effects. Its oncology focus in on melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dematitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH10 as a topical treatment for atopic dermatitis and psoriasis.

Provision Holding, Inc.
Provision Holding, Inc. (PVHO)
Industry Sector: Technology - Media and Internet

Provision Interactive Technologies, Inc., a subsidiary of the publicly traded company Provision Holding, Inc. (OTCQB: PVHO), is the leading purveyor of intelligent interactive 3D holographic display technologies, software, and integrated solutions for both commercial and consumer focused applications.

Provision's 3D holographic display systems represent a revolutionary technology that provides the projection of full color, high-resolution videos into space detached from the screen, without any special glasses. Provision is currently the market leader in true 3D consumer advertising display products being implemented by innovative, consumer-focused companies.

Pulmatrix (PULM)
Industry Sector: Life Science and Healthcare

Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for lung disease patients. In addition, Pulmatrix is pursuing opportunities in major pulmonary diseases through collaborations, including PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease (COPD). Pulmatrix's product candidates are based on iSPERSE™, its proprietary dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes.

PURE Bioscience, Inc.
PURE Bioscience, Inc. (PURE)
Industry Sector: Life Science and Healthcare

PURE Bioscience, Inc. is commercializing its patented SDC-based antimicrobial products (FDA approved PURE Control® and EPA registered PURE® Hard Surface) providing less toxic and more effective food safety solutions for food processors/manufacturers, retailers and restaurants. SDC (silver dihydrogen citrate) test data demonstrate proven superior efficacy over a broad spectrum of pathogens, including E. coli, Salmonella, Listeria and Norovirus, when compared with toxic products currently in use in the food industry. The processing aids markets for fresh produce and for raw poultry represent a $650 million US opportunity for PURE Control. The growing US food-safety-solutions industry is a $2+ billion total opportunity and it is PURE’s 3–5 year goal to achieve at least 10+ % share of these markets to prevent foodborne illnesses. PURE is headquartered in El Cajon, California (San Diego metropolitan area).

Q BioMed Inc.
Q BioMed Inc. (QBIO)
Industry Sector: Life Science and Healthcare

Q BioMed Inc. ''Q`` is a biomedical acceleration and development company. We are focused on acquiring undervalued biomedical assets. Q is dedicated to providing these target assets, strategic resources, developmental support, and expansion capital to accelerate developmental and ultimately, to provide products to patients in need‏.

Rand Capital Corporation
Rand Capital Corporation (RAND)
Industry Sector: Financials and Asset Management Services

Rand Capital Corporation provides investors the ability to participate in venture capital opportunities through an investment in the Company’s stock. Rand is a Business Development Company (BDC), and its wholly-owned subsidiary is licensed by the U.S. Small Business Administration (SBA) as a Small Business Investment Company (SBIC). Rand focuses its investments in early or expansion stage companies with strong leadership that are bringing to market new or unique products, technologies or services that have a high potential for growth.

Relmada Therapeutics Inc.
Relmada Therapeutics Inc. (RLMD)
Industry Sector: Life Science and Healthcare

Relmada Therapeutics is a clinical-stage, publicly traded biopharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The Company has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol.

RiceBran Technologies
RiceBran Technologies (RIBT)
Industry Sector: Life Science and Healthcare

RiceBran Technologies is a human ingredient and functional food company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. RiceBran Technologies has proprietary and patented intellectual property that allows us to convert rice bran, one of the world’s most underutilized food sources, into a number of highly nutritious human food ingredients and functional foods. Our target markets include human food manufacturers, functional food and supplement manufacturers and animal nutrition manufacturers, both domestically and internationally. Additionally, RiceBran Technologies formulates and manufactures turnkey functional foods at our Healthy Natural, Inc. subsidiary. These finished product formulas utilize RiceBran Technologies’ proprietary and patented ingredients to target Nutraceutical and Functional Food markets worldwide.

SecureCom Mobile Inc.
SecureCom Mobile Inc. (SCQNF)
Industry Sector: Technology - Media and Internet

SecureCom Mobile Inc. provides a suite of encryption technology solutions in securing mobile phone conversations and digital messaging for enterprise and consumer markets. Under the brand SecurePair™, the Company's unique open-source technology enables people to communicate in complete privacy and with ease, using voice, text and data messaging. SecureCom employs cryptographically strong algorithms and protocols to shield communications from surveillance and analysis, thereby ensuring total privacy.Securecom set out to complete a new platform for securing end-to-end communications with capabilities inclusive, but beyond what the mass-market solutions offer. Specifically addressed are enterprise needs for strong compliance controls, a unified solution to support more advanced types of commercial transactions within the same solution, and an enterprise grade communications framework without a "central hub" failure model endemic to mass-market 'freemium' chat solutions. SecureCom is led by President & CEO Roland Bopp, who previously served as Chairman, President & CEO of the Americas for Deutsche Telekom Inc., a subsidiary of Deutsche Telekom of Germany based in NYC.

SG Blocks
SG Blocks (SGBX)
Industry Sector: Industrials

SG Blocks is the premier innovator of commercial and private environments utilizing code-engineered cargo shipping containers. Providing solutions to some of the world's biggest companies and government agencies, SG Blocks offers cost effective container-construction technology that exceeds many standard building code requirements. The Company works with developers, architects, builders and owners to achieve faster execution, stronger high-value buildings, and greener construction.

Soligenix, Inc.
Soligenix, Inc. (SNGX)
Industry Sector: Life Science and Healthcare

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The BioTherapeutics division is developing three drug candidates. SGX301 (synthetic hypericin) for the early stage treatment of cutaneous T-cell lymphoma (CTCL) is currently enrolling patients in a Pivotal Phase 3 trial. The Phase 2 proof-of-concept study for SGX942, our novel innate defense regulator, demonstrated positive preliminary results in reducing the duration of severe oral mucositis in head and neck cancer patients. SGX203, a proprietary formulation of oral beclomethasone) is being developed for the front-line treatment of pediatric Crohn’s disease and will soon be initiating a Pivotal Phase 3 trial. The cornerstone of the vaccine/biodefense franchise is the ThermoVax® heat stabilization platform technology which eliminates cold chain production and storage concerns. The compounds in this division are fully funded through contracts from several US government agencies.

Staffing 360 Solutions, Inc.
Staffing 360 Solutions, Inc. (STAF)
Industry Sector: Software and Business Services

Staffing 360 Solutions, Inc. is a high-growth public company in the staffing sector engaged in the execution of a global buy-and-build strategy through the acquisition of domestic and international staffing organizations in the US and the UK. The Company believes the staffing industry offers unique opportunities for accretive acquisitions that will drive its annual revenues to $300 million. As part of its targeted consolidation model, the Company is pursuing acquisition targets in the finance and accounting, administrative, engineering and IT staffing space. The company has already increased revenues from less than $1 million in fiscal 2013 to over $170 million on a current annualized basis. Management believes Staffing 360 Solutions is positioned to capitalize on the extraordinary demand for staffing services around the globe, with an unequivocal commitment to building long-term shareholder value.

StemCells, Inc.
StemCells, Inc. (STEM)
Industry Sector: Life Science and Healthcare

StemCells, Inc. is engaged in the research and development of therapeutics using the Company's proprietary human neural stem cells for treating disorders of the central nervous system. The Company has completed four Phase I/II clinical trials including one in dry age related macular degeneration and one in spinal cord injury. The Company has reported positive results in both of these studies. The Company currently is pursuing a follow on Phase II study in chronic cervical spinal cord injury. Interim results on the first six patients in Cohort I of the spinal cord injury studies showed gains in muscle strength in 5 of the 6 patients. Four of those 5 subjects also demonstrated improved performance on functional tasks assessing dexterity and fine motor skills. In addition four of the six patients had improvement in the anatomic level of injury as defined by the ISNCSCI assessment of at least one level. Final results from this Cohort will be available second quarter 2016 with final study results available 2017.

Sysorex Global Holdings Corp.
Sysorex Global Holdings Corp. (SYRX)
Industry Sector: Technology - Media and Internet

Sysorex Global Holdings Corp. is a leading provider of Information Technology Support Services for enterprise level IT environments including full life cycle software development, interface, integration, operational support, and IT Network Infrastructure Modernization Services. With over 30 years of operating history, they provide a wide range of consulting, systems engineering, cyber security, data analytics and program management expertise.

Terra Tech Corp
Terra Tech Corp (TRTC)
Industry Sector: Retail and Consumer Products

Terra Tech Corp is a vertically integrated, cannabis-focused agriculture company. Through its subsidiary, MediFarm, Terra Tech cultivates and produces medical cannabis. The Company recently launched its IVXXTM brand of high-quality medical cannabis produced in Company-owned labs and sold in select dispensaries throughout California and Nevada. The Company has also recently opened its first medical cannabis dispensaries, under the name Blüm, in California and Nevada which offer a broad selection of the highest quality medical cannabis products to patients, including flowers, concentrates and edibles.

Through its wholly-owned subsidiary, Edible Garden, Terra Tech cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Walmart, Krogers, and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, Pennsylvania and the Midwest

Translux Corporation
Translux Corporation (TNLX)
Industry Sector: Technology - Media and Internet

Trans-Lux Corporation is a premier global supplier of engaging LED-based digital display solutions and lighting for a wide range of business, sports, residential, and government applications. Only Trans-Lux delivers truly integrated LED display and lighting solutions that can transform venues into events with the highest levels of performance and cost-efficiency.

A single source global solution provider, Trans-Lux designs, manufactures, markets and services LED display and lighting solutions.

U.S. Geothermal Inc.
U.S. Geothermal Inc. (HTM)
Industry Sector: Energy and Natural Resources

U.S. Geothermal Inc., is a leading and profitable renewable energy company focused on the development, production and sale of electricity from geothermal energy. The Company is currently operating geothermal power projects at Neal Hot Springs, Oregon, San Emidio, Nevada and Raft River, Idaho for a total power generation capacity of approximately 45 megawatts. The Company has advanced stage development projects at the Geysers, in California, and a second phase project at San Emidio, Nevada and El Ceibillo, located near Guatemala City, Guatemala. Exploration projects include Crescent Valley, Nevada, and Vale, Oregon. U.S. Geothermal’s growth strategy is to reach 200MW’s of production by 2020, through a combination of internal development and strategic acquisitions.

VBI Vaccines Inc.
VBI Vaccines Inc. (VBIV)
Industry Sector: Life Science and Healthcare

VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI's eVLP vaccine platform allows for the design of enveloped ("e") virus-like particle ("VLP") vaccines that closely mimic the target virus. The company's lead eVLP asset is a prophylactic Cytomegalovirus ("CMV") vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials. The company's second platform is a thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI has completed proof of concept thermostability studies on a number of vaccine and biologic targets. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.

Viking Therapeutics
Viking Therapeutics (VKTX)
Industry Sector: Life Science and Healthcare

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The company's lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, in Phase 2 development for the treatment and prevention of lean body mass loss in patients who have undergone hip fracture surgery, and VK2809, a small molecule thyroid beta agonist entering Phase 2 development for hypercholesterolemia and fatty liver disease. Viking is also developing novel and selective agonists of the thyroid beta receptor for adrenoleukodystrophy, as well as two earlier-stage programs targeting metabolic diseases and anemia.

Village Farms International
Village Farms International (VFFIF)
Industry Sector: Retail and Consumer Products

Village Farms is one of the largest producers, marketers and distributors of premium-quality, greenhouse-grown tomatoes, bell peppers and cucumbers in North America.This premium product as well as premium product produced under exclusive arrangements with other greenhouse producers is grown in sophisticated, highly efficient and intensive agricultural greenhouse facilities located in British Columbia and Texas.Product is marketed and distributed under the Village Farms® brand primarily to retail grocers and dedicated fresh food distributors throughout the United States and Canada.Since its inception, Village Farms has been guided by sustainable growing methods and producing vegetables 365 days a year from its facilities that are healthier for people and the planet.Village Farms is Good for the Earth®.

Vishay Precision Group, Inc.
Vishay Precision Group, Inc. (VPG)
Industry Sector: Industrials

Vishay Precision Group, Inc. (VPG) is an internationally recognized designer, manufacturer and marketer of: components based on its resistive foil technology; sensors; and sensor-based systems specializing in the growing markets of stress, force, weight, pressure, and current measurements. VPG is a market leader of foil technology products, providing ongoing technology innovations in precision foil resistors and foil strain gages, which are the foundation of the company's force sensors products and its weighing and control systems. The product portfolio consists of a variety of well-established brand names recognized for precision and quality in the marketplace.

VolitionRx Limited
VolitionRx Limited (VNRX)
Industry Sector: Life Science and Healthcare

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present.

VolitionRx’s goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx’s research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.

Weyland Tech, Inc.
Weyland Tech, Inc. (WEYL)
Industry Sector: Technology - Media and Internet

Weyland Tech's CreateApp platform enables small-medium-sized businesses ("SMB's") to create a mobile application ("app") without the need of technical knowledge and background. The CreateApp platform is offered in 11 languages and 48 functions, creating a simple, easy-to-use app for business owners to engage customers.

SMB's can increase sales, reach more customers and promote their products and services via a simple easy to build mobile app at an affordable and cost-effective manner.

The underlying dynamics of the Southeast and South Asia markets, where the Company has a focus, create a compelling opportunity for Weyland Tech to grow significantly - SMB's in both regions, as a percentage of total businesses, exceed 95%.

Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (XTNT)
Industry Sector: Life Science and Healthcare

Xtant Medical Holdings, Inc. develops, manufactures and markets class-leading regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.

* Important note about presenting companies

The information contained on this website should not be construed as an endorsement of any entity included herein, is not intended to be used, and cannot be used, for the purpose of promoting, marketing, or recommending to another party any transaction or matter. Neither the information nor the Marcum MicroCap Conference shall constitute an offer or the solicitation of an offer to sell or buy any security. Information about the presenting companies, and information contained on presenting company websites has been prepared by and is the responsibility of each of the individual presenting companies. Marcum has not reviewed such information and does not provide any assurance that such information is accurate or complete.
© 2016 Marcum LLP. All Rights Reserved.
Privacy | Legal | Sitemap |